EUVIMEDEUVIMED entdecken
Crossref

Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features

P. Stougie, N. F. Frei, V. Pappalardo, A. M. Khoshiwal, H. Yu, R. Menezes, L. C. Duits, J. Bergman, M. Stachler

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S78

DOI: 10.1055/s-0044-1782858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von P. Stougie und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Current surveillance for low-risk Barrett's Esophagus (BE) patients is burdensome, cost-ineffective and dependent on subjective histological assessment of dysplasia with high inter-observer variability. This study aims to identify genomic features that can be identified in a clinically translatable targeted sequencing panel, enhancing the stratification of low-risk BE patients and enabling personalized surveillance strategies.

Methods

BE patients identified as progressors to early esophageal adenocarcinoma or non-progressors from a large community-based cohort, were matched for age, sex and BE segment length. DNA from baseline and prior non-dysplastic biopsies was sequenced using a targeted capture-based panel designed to detect mutations and copy number changes (CNV). Detected mutations, homozygous deletions, and high-level amplifications were filtered for likely pathogenic events. We performed logistic regression, covariate analysis, and penalized mixed-effect models. A joint model for survival and mixed effects was implemented to analyze the data distributed over space and time.

Results

331 baseline samples and 214 temporal samples, accounting for 105 progressors who progressed after a median 4 (IQR 2.4-7.2) years, and 115 non-progressors who had a median progression-free follow-up of 6 (IQR 4.3-7.3) years, were analyzed. TP53 mutations strongly predict risk (p

Zitieren

APA

Stougie, P., Frei, N. F., Pappalardo, V., Khoshiwal, A. M., Yu, H., Menezes, R., Duits, L. C., Bergman, J., & Stachler, M. (2024). Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features. Endoscopy, 56(S 02 S 02), S78. https://doi.org/10.1055/s-0044-1782858

Vancouver

Stougie P, Frei NF, Pappalardo V, Khoshiwal AM, Yu H, Menezes R, et al. Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features. Endoscopy. 2024;56(S 02 S 02):S78. doi:10.1055/s-0044-1782858

BibTeX
@article{Stougie2024,
  author = {Stougie, P. and Frei, N. F. and Pappalardo, V. and Khoshiwal, A. M. and Yu, H. and Menezes, R. and Duits, L. C. and Bergman, J. and Stachler, M.},
  title = {Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S78},
  doi = {10.1055/s-0044-1782858}
}
Kostenlos starten →